Product Datasheet

 
Product Description
 
Product: COVID-19 Convalescent Patient Antibody, IgG Fraction
Catalog Number: COVID-GF
Product Page: https://www.mol-innov.com/products/IHUCOVIGGGFLY50UG
Description: SARS-CoV-2 is the novel coronavirus that causes CoronaVirus Disease 2019 (COVID-19). This IgG fraction is purified by immobilized Protein A from pooled sera collected from convalescent COVID-19 patients. Serum was collected at least two weeks post symptom development from patients with positive COVID-19 PCR and serology tests. This antibody preparation is strongly positive in the Molecular Innovations SARS-CoV-2 IgG Seroconversion ELISA Kit and can be useful as a positive control or calibrator in a variety of serological assays. Add PBS to desired volume, aliquot and freeze unused portion.
Recommended Storage: SAMPLE
Minimum Shelf Life: 276.50
Source: Lyophilized
Molecular Weight: Antibodies
Extinction Coefficient: 160,000
Antigen: -20 C
Target: Lyophilized powder
Target Molecular Weight: COVID-19
Host: 416.5
Clonality: 30
Isotype: Human serum
Clone: s
Applications: Cold pack
Cross-reactivity: 5 years from delivery
 
Sample Characteristics
 
Lot Number: COVID-GF-IHUCOVIGGGFLY100UG
Aliquot: 1 x Human IgG from Covid-19 Convalescent Plasma Fractionated Purified Lyophilized 100ug
Concentration: 395
Volume: 595
Titer: 0.05M Sodium Phosphate; 0.1M NaCl; 1mM EDTA; pH 6.6
Buffer: SAMPLE
Form: 0.05 mg
Preservative: 0.005 ml before lyophilization
 
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet.
 
For in vitro laboratory use only
 
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com